Document is current
Any future updates will be listed below
-
Authors
Kuehl, Malte https://orcid.org/0000-0003-4167-2498
Schaub, Darius P. https://orcid.org/0009-0000-8685-3263
Carli, Francesco
Heumos, Lukas
Hellmig, Malte https://orcid.org/0000-0002-6692-5618
Fernández-Zapata, Camila https://orcid.org/0000-0003-4795-6053
Kaiser, Nico https://orcid.org/0009-0006-6054-2831
Schaul, Jonathan
Kulaga, Anton https://orcid.org/0000-0001-7449-7054
Usanov, Nikolay
,
Koutrouli, Mikaela https://orcid.org/0000-0002-8953-3561
Ergen, Can
Palla, Giovanni
Krebs, Christian F. https://orcid.org/0000-0003-2739-5578
Panzer, Ulf
Bonn, Stefan https://orcid.org/0000-0003-4366-5662
Lobentanzer, Sebastian
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Puelles, Victor G. https://orcid.org/0000-0002-7735-5462
- License Information
-
More Information
Article History
First Online: 6 November 2025
Competing interests
: M.K. is an employee of and holds an ownership interest in KH Biotechnology, which provides consulting services to Lamin Labs. L.H. is an employee of Lamin Labs. J.S.-R. reports in the last 3 years funding from GSK and Pfizer and fees or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, Grunenthal, Tempus and Moderna.
